Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001247011 | SCV001420408 | uncertain significance | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 796 of the ELP1 protein (p.Met796Val). This variant is present in population databases (rs748482757, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 971264). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002484385 | SCV002778696 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2021-10-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001830001 | SCV002082081 | uncertain significance | Familial dysautonomia | 2020-05-11 | no assertion criteria provided | clinical testing |